UCSF

Tagged: Biophysics Graduate Program (BP)

Celebrating the 100th birthday of Edward Leong Way

Edward (Eddie) Leong Way, BS, MS, PhD, celebrated his 100th birthday on July 1, 2016, with more than 70 colleagues, friends, and family at the UCSF Mission Bay Conference Center.

Research: pediatric meningitis dosing; cancer drug resistance; gene-testing economics

Computer models provide optimal dosing for pediatric TB meningitis

Abate honored by World Economic Forum at meeting in China

Our faculty member Adam Abate, PhD, was selected by the World Economic Forum (WEF) as one of 45 exceptional Young Scientists—all under the age of 40—each of whom has contributed to advancing the frontiers of science, engineering, or technology in areas of high societal impact.

Shoichet study sheds light on “dark” cell receptors, potential drug targets

More than a quarter of all drugs work by targeting one of a large family of proteins called G-protein-coupled receptors (GPCRs). Hundreds of different GPCRs are embedded in cell membranes, converting stimuli from the outside world—neurotransmitters, hormones, even light—into intracellular signals...

Update from the Dean - Fall/Winter 2015

Strategic planning; Recently received research funding: cancer, Alzheimer's, HIV, type 2 diabetes (Kroetz, Keiser, Gross, Roy); Recent faculty publications: fibrosis, biofilms, gout (DeGrado, Yang, Giacomini); Collaborations and partnerships; Patient care: SB 493, scope of practice for California...

Desai elected to the National Academy of Medicine

UCSF School of Pharmacy faculty member Tejal Desai, PhD, has been newly elected to the National Academy of Medicine (NAM), formerly known as the Institute of Medicine (IOM).

Gartner named one of Popular Science’s “Brilliant 10” of 2015

The next frontier in developing therapies for cancer and other diseases could come through studying organ development or tumor growth in living humans. Problem is, there’s no ethical way of doing that using current technology.

Zev Gartner, PhD, has focused on the next best thing: His lab is...

UCSF-Amgen Symposium

The UCSF School of Pharmacy Industry Outreach Program presents a UCSF-Amgen Symposium.

This event will comprise two sessions:

Antibody Network partners with Celgene to develop cancer therapies

A new collaboration between Celgene Corp. and the Recombinant Antibody Network (RAN) will support the development of next-generation, antibody-based cancer therapies.

Pages